Page 13 - Exact Sciences News Today

Exact Sciences Corp (EXAS) Announces 17% Revenue Increase and Provides Optimistic 2024 Outlook

MADISON, Wis. (AP) — MADISON, Wis. (AP) — Exact Sciences Corp. (EXAS) on Wednesday reported a loss of $49.8 million in its fourth quarter.

The rise of GLP-1 weight-loss drugs has arguably been the second-hottest trend in the stock market right now — second to generative artificial intelligence (AI). Undoubtedly, the “GLP-1 run” has brought a great deal of enthusiasm to the biotechnology and healthcare scenes. However, I don’t expect it’ll be the last ground-breaking innovation from the health space over the coming years. As AI and biotech join forces, there’s no telling where the healthcare...

That’s the theory behind the March 18 Wisconsin Tech Summit at Green Bay’s Lambeau Field.

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) CFO Jeffrey Thomas Elliott sold 1,888 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $61.43, for a total value of $115,979.84. Following the completion of the transaction, the chief financial officer now […]

Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) Director D Scott Coward sold 1,376 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $61.43, for a total value of $84,527.68. Following the completion of the transaction, the director now directly owns […]

Earnings season picks back up for the Club next week, with four holdings set to report quarterly results.

Rhenman & Partners Asset Management AB trimmed its stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 8.6% in the third quarter, Holdings Channel.com reports. The firm owned 160,000 shares of the medical research company’s stock after selling 15,000 shares during the quarter. Rhenman & Partners Asset Management AB’s holdings in Exact Sciences were […]

Akumin (NASDAQ:AKUMQ – Get Free Report) and Exact Sciences (NASDAQ:EXAS – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk. Earnings and Valuation This table compares Akumin and Exact […]

Madison-based NVNG Investment Advisors announced this week it’s closed its first fund of funds with $50 million in commitments.